Stents and failing vein grafts: Are we any wiser after ISAR?

The Lancet

Volumn 378, Issue 9796, 2011, Pages 1054-1055

  Taggart, David P ^a   Banning, Adrian P ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DRUG ELUTING STENT; GRAFT FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MORTALITY; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAPHENOUS VEIN GRAFT; STENT; TREATMENT OUTCOME; VEIN GRAFT;

EID: 80052971029     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61340-8     Document Type: Note

References (11)

1. AP Kappetein, TE Feldman, MJ Mack et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 2011 10.1093/eurheartj/ehr213 published online June 22.
2. G Fitzgibbon, H Kafka, A Leach, WJ Keon, GD Hooper, JR Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years J Am Coll Cardiol 28 1996 616 626 (Pubitemid 26288642)
3. DP Taggart, R D'Amico, DG Altman Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries Lancet 358 2001 870 875 (Pubitemid 32900568)
4. DP Taggart, DG Altman, AM Gray ART Investigators Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART) Eur Heart J 31 2010 2470 2481
5. B Bridgewater, B Keogh on behalf of the Society for Cardiothoracic Surgery in Great Britain and Ireland Sixth National Adult Cardiac Surgical Database Report 2008 2009 Dendrite Clinical Systems Henley-on-Thames
6. M Tabata, JD Grab, Z Khalpey et al. Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database Circulation 120 2009 935 940
7. ES Brilakis, TY Wang, SV Rao et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry JACC Cardiovasc Interv 3 2010 1068 1073
8. T Schachner Pharmacologic inhibition of vein graft neointimal hyperplasia J Thorac Cardiovasc Surg 131 2006 1065 1072
9. L Testa, P Agostoni, P Vermeersch et al. Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis EuroIntervention 6 2010 527 536
10. J Mehilli, J Pache, M Abdel-Wahab for the Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial Lancet 2011 10.1016/S0140-6736(11)61255-5 published online Aug 28.
11. H Roukoz, AA Bavry, ML Sarkees et al. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up Am J Med 122 2009 581.e1 10